These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 26055805)

  • 1. Reverse chemomodulatory effects of the SIRT1 activators resveratrol and SRT1720 in Ewing's sarcoma cells: resveratrol suppresses and SRT1720 enhances etoposide- and vincristine-induced anticancer activity.
    Sonnemann J; Kahl M; Siranjeevi PM; Blumrich A; Blümel L; Becker S; Wittig S; Winkler R; Krämer OH; Beck JF
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):17-26. PubMed ID: 26055805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arsenic trioxide potentiates the effectiveness of etoposide in Ewing sarcomas.
    Boehme KA; Nitsch J; Riester R; Handgretinger R; Schleicher SB; Kluba T; Traub F
    Int J Oncol; 2016 Nov; 49(5):2135-2146. PubMed ID: 27665785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RETRA exerts anticancer activity in Ewing's sarcoma cells independent of their TP53 status.
    Sonnemann J; Grauel D; Blümel L; Hentschel J; Marx C; Blumrich A; Focke K; Becker S; Wittig S; Schinkel S; Krämer OH; Beck JF
    Eur J Cancer; 2015 May; 51(7):841-51. PubMed ID: 25801700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The sirtuin 1/2 inhibitor tenovin-1 induces a nonlinear apoptosis-inducing factor-dependent cell death in a p53 null Ewing's sarcoma cell line.
    Marx C; Marx-Blümel L; Lindig N; Thierbach R; Hoelzer D; Becker S; Wittig S; Lehmann R; Slevogt H; Heinzel T; Wang ZQ; Beck JF; Sonnemann J
    Invest New Drugs; 2018 Jun; 36(3):396-406. PubMed ID: 29150734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of Ecteinascidin-743 against drug-sensitive and -resistant bone tumor cells.
    Scotlandi K; Perdichizzi S; Manara MC; Serra M; Benini S; Cerisano V; Strammiello R; Mercuri M; Reverter-Branchat G; Faircloth G; D'Incalci M; Picci P
    Clin Cancer Res; 2002 Dec; 8(12):3893-903. PubMed ID: 12473605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sirtuin 1 activator SRT1720 suppresses inflammation in an ovalbumin-induced mouse model of asthma.
    Ichikawa T; Hayashi R; Suzuki K; Imanishi S; Kambara K; Okazawa S; Inomata M; Yamada T; Yamazaki Y; Koshimizu Y; Miwa T; Matsui S; Usui I; Urakaze M; Matsuya Y; Sasahara M; Tobe K
    Respirology; 2013 Feb; 18(2):332-9. PubMed ID: 23062010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resveratrol Protects Against Pulmonary Arterial Hypertension in Rats via Activation of Silent Information Regulator 1.
    Yu L; Tu Y; Jia X; Fang K; Liu L; Wan L; Xiang C; Wang Y; Sun X; Liu T; Yu D; Cao W; Song Y; Fan Y
    Cell Physiol Biochem; 2017; 42(1):55-67. PubMed ID: 28494457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1.
    Pacholec M; Bleasdale JE; Chrunyk B; Cunningham D; Flynn D; Garofalo RS; Griffith D; Griffor M; Loulakis P; Pabst B; Qiu X; Stockman B; Thanabal V; Varghese A; Ward J; Withka J; Ahn K
    J Biol Chem; 2010 Mar; 285(11):8340-51. PubMed ID: 20061378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SIRT1-Activating Compounds (STAC) Negatively Regulate Pancreatic Cancer Cell Growth and Viability Through a SIRT1 Lysosomal-Dependent Pathway.
    Chini CC; Espindola-Netto JM; Mondal G; Guerrico AM; Nin V; Escande C; Sola-Penna M; Zhang JS; Billadeau DD; Chini EN
    Clin Cancer Res; 2016 May; 22(10):2496-507. PubMed ID: 26655844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How effective is dose-intensive/myeloablative therapy against Ewing's sarcoma/primitive neuroectodermal tumor metastatic to bone or bone marrow? The Memorial Sloan-Kettering experience and a literature review.
    Kushner BH; Meyers PA
    J Clin Oncol; 2001 Feb; 19(3):870-80. PubMed ID: 11157041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone deacetylase inhibitors induce cell death and enhance the apoptosis-inducing activity of TRAIL in Ewing's sarcoma cells.
    Sonnemann J; Dreyer L; Hartwig M; Palani CD; Hong le TT; Klier U; Bröker B; Völker U; Beck JF
    J Cancer Res Clin Oncol; 2007 Nov; 133(11):847-58. PubMed ID: 17486365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of baicalein on proliferation, apoptosis, migration and invasion of Ewing's sarcoma cells.
    Ye C; Yu X; Zeng J; Dai M; Zhang B
    Int J Oncol; 2017 Dec; 51(6):1785-1792. PubMed ID: 29039470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effects of SRT1720 on the apoptosis of rabbit chondrocytes by activating SIRT1 via p53/bax and NF-κB/PGC-1α pathways.
    Liu B; Lei M; Hu T; Yu F; Xiao DM; Kang H
    J Huazhong Univ Sci Technolog Med Sci; 2016 Jun; 36(3):350-355. PubMed ID: 27376802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic anticancer activity of combined ATR and ribonucleotide reductase inhibition in Ewing's sarcoma cells.
    Sturm MJ; Henao-Restrepo JA; Becker S; Proquitté H; Beck JF; Sonnemann J
    J Cancer Res Clin Oncol; 2023 Sep; 149(11):8605-8617. PubMed ID: 37097390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticancer effects of the PLK4 inhibitors CFI-400945 and centrinone in Ewing's sarcoma cells.
    Kerschner-Morales SL; Kühne M; Becker S; Beck JF; Sonnemann J
    J Cancer Res Clin Oncol; 2020 Nov; 146(11):2871-2883. PubMed ID: 32770382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancy.
    Nakatani F; Ferracin M; Manara MC; Ventura S; Del Monaco V; Ferrari S; Alberghini M; Grilli A; Knuutila S; Schaefer KL; Mattia G; Negrini M; Picci P; Serra M; Scotlandi K
    J Pathol; 2012 Apr; 226(5):796-805. PubMed ID: 21960059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro antitumor effect of sodium butyrate and zoledronic acid combined with traditional chemotherapeutic drugs: a paradigm of synergistic molecular targeting in the treatment of Ewing sarcoma.
    Dos Santos MP; de Farias CB; Roesler R; Brunetto AL; Abujamra AL
    Oncol Rep; 2014 Feb; 31(2):955-68. PubMed ID: 24316794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticancer effects of the p53 activator nutlin-3 in Ewing's sarcoma cells.
    Sonnemann J; Palani CD; Wittig S; Becker S; Eichhorn F; Voigt A; Beck JF
    Eur J Cancer; 2011 Jun; 47(9):1432-41. PubMed ID: 21334198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone.
    Grier HE; Krailo MD; Tarbell NJ; Link MP; Fryer CJ; Pritchard DJ; Gebhardt MC; Dickman PS; Perlman EJ; Meyers PA; Donaldson SS; Moore S; Rausen AR; Vietti TJ; Miser JS
    N Engl J Med; 2003 Feb; 348(8):694-701. PubMed ID: 12594313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RT-PCR evaluation of peripheral blood, bone marrow and peripheral blood stem cells in children and adolescents undergoing VACIME chemotherapy for Ewing's sarcoma and alveolar rhabdomyosarcoma.
    Thomson B; Hawkins D; Felgenhauer J; Radich J
    Bone Marrow Transplant; 1999 Sep; 24(5):527-33. PubMed ID: 10482938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.